FDA outlines path for lower-priced biotech drugs

February 9, 2012 11:08:42 AM PST
The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications that have never before faced generic competition in the U.S.

Load Comments